Featured Research

from universities, journals, and other organizations

Hopkins Researchers Use Diffusion MRI Technique To Monitor Ultrasound Uterine Fibroid Treatment

Date:
August 10, 2005
Source:
Johns Hopkins Medical Institutions
Summary:
Johns Hopkins researchers have, for what is believed to be the first time, used a magnetic resonance imaging (MRI) technique called diffusion-weighted MRI (DWI), a technique that images the movement, or diffusion, of water molecules in tissues, to successfully determine the effectiveness of high-intensity focused ultrasound for treating uterine fibroids. Uterine fibroids are noncancerous tumors that line the uterine wall and can cause intense pain and bleeding. The study appears in the July edition of Radiology.

Johns Hopkins researchers have, for what is believed to be the firsttime, used a magnetic resonance imaging (MRI) technique calleddiffusion-weighted MRI (DWI), a technique that images the movement, ordiffusion, of water molecules in tissues, to successfully determine theeffectiveness of high-intensity focused ultrasound for treating uterinefibroids. Uterine fibroids are noncancerous tumors that line theuterine wall and can cause intense pain and bleeding. The study appearsin the July edition of Radiology.

Ultrasound treatment works by directing focused ultrasound energythat heats the targeted tissue to induce cell damage or death withoutdamaging the surrounding tissue. Because it's noninvasive, thetreatment provides a desirable alternative to conventional surgery andwas undergoing clinical trials nationally and was recently given FDAapproval.

When fibroids or other tissues are damaged or destroyed by ultrasoundtreatment, water molecules are trapped within the tissue because thecellular pumps that control the movement of water into or out of cellsno longer function properly. By measuring the movement of this waterusing DWI, the researchers hoped to better gauge the impact oftreatment on the fibroids by using a quantitative biophysical parametercalled the apparent diffusion coefficient (ADC).

Currently, treatment success is determined using regular MRIwith a contrast agent (a dye injected into the patient to enhance theresulting image). However, the image produced during this proceduredoes not precisely show functional information on the degree of fibroiddestruction. Therefore, physicians also rely on questionnairesadministered to patients after their fibroid treatment, which often arevery subjective and unreliable.

In the study, 14 patients with uterine fibroids received ultrasoundtreatment and subsequent MR imaging using three different MRtechniques: conventional MRI, MRI with contrast material, and DWI MRI.Results showed significantly greater signal intensity on DWI ofultrasound treated fibroids than on the images of untreated fibroids ortreated fibroids obtained with the other MR methods. These results wereconfirmed in the 12 patients who took part in the six-month follow upstudy. Also observed were differences in the ADC. The DWI technique wasable to map the ADC in fibroids, showing lower ADC values in treatedfibroids than in surrounding tissue, a measure of restricted cellularwater flow due to the ultrasound treatment.

"While these results are preliminary and more research is needed, theystrongly suggest that the diffusion-weighted MR technique providesimages that show functional changes and the extent of fibroid damagefrom treatment. DWI may be useful for monitoring the effects ofultrasound treatment on uterine fibroids," says Michael Jacobs, Ph.D.,assistant professor of radiology and oncology at the Russell H. MorganDepartment of Radiology and Radiological Science at Johns Hopkins. "Theresults also suggest that this imaging technique may be useful formonitoring other focused ultrasound treatments for lesions in theprostate, and breast, when available." The other co-authors of thestudy were Hyun "Kevin" Kim, M.D. and Edward Herskovits, M.D., Ph.D.This study was supported in part by grants from the National Institutesof Health.



Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "Hopkins Researchers Use Diffusion MRI Technique To Monitor Ultrasound Uterine Fibroid Treatment." ScienceDaily. ScienceDaily, 10 August 2005. <www.sciencedaily.com/releases/2005/08/050809065346.htm>.
Johns Hopkins Medical Institutions. (2005, August 10). Hopkins Researchers Use Diffusion MRI Technique To Monitor Ultrasound Uterine Fibroid Treatment. ScienceDaily. Retrieved October 2, 2014 from www.sciencedaily.com/releases/2005/08/050809065346.htm
Johns Hopkins Medical Institutions. "Hopkins Researchers Use Diffusion MRI Technique To Monitor Ultrasound Uterine Fibroid Treatment." ScienceDaily. www.sciencedaily.com/releases/2005/08/050809065346.htm (accessed October 2, 2014).

Share This



More Health & Medicine News

Thursday, October 2, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pregnancy Spacing Could Have Big Impact On Autism Risks

Pregnancy Spacing Could Have Big Impact On Autism Risks

Newsy (Oct. 1, 2014) A new study says children born less than one year and more than five years after a sibling can have an increased risk for autism. Video provided by Newsy
Powered by NewsLook.com
Ebola Patient Told Hospital He Was from Liberia

Ebola Patient Told Hospital He Was from Liberia

AP (Oct. 1, 2014) The first Ebola patient diagnosed in the U.S. initially went to a Dallas emergency room last week but was sent home, despite telling a nurse that he had been in disease-ravaged West Africa, the hospital acknowledged Wednesday. (Oct. 1) Video provided by AP
Powered by NewsLook.com
Robotic Hair Restoration

Robotic Hair Restoration

Ivanhoe (Oct. 1, 2014) A new robotic procedure is changing the way we transplant hair. The ARTAS robot leaves no linear scarring and provides more natural results. Video provided by Ivanhoe
Powered by NewsLook.com
Insertable Cardiac Monitor

Insertable Cardiac Monitor

Ivanhoe (Oct. 1, 2014) A heart monitor the size of a paperclip that can save your life. The “Reveal Linq” allows a doctor to monitor patients with A-Fib on a continuous basis for up to 3 years! Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins